Prof Julien Pottecher is an expert in Critical care at Hôpitaux Universitaires de Strasbourg (France). As of October 2026, ScienceLeadR ranks Julien Pottecher in the top 1% of experts worldwide for Pneumonia, Coronavirus Infections and COVID-19. Julien Pottecher has authored 246 publications, the most recent in 2026, and is an investigator in 63 clinical trials, 10 of them ongoing. SLR score: 1,459 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Julien Pottecher Hôpitaux Universitaires de Strasbourg France
1 459 ScienceLeadR Reputation 1459
Network Map

Critical care

Subspecialties: Anesthesiology - Public Health - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2004 - 2026

Source: PubMed

Hôpitaux Universitaires de Strasbourg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 246

Citations

Citations: 12 033 1st author: 24 Last author: 26 Unique author: 0


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Appendicular Versus Non-Appendicular Community-Acquired Intra-Abdominal Infections: A Post-Hoc Analysis of the PERICOM Multicenter Study.
PMID 42792060 — peritonitis, intraabdominal infections, documentation, appendicitis, infections
Antibiotics (Basel)20260
Does the Initial Injury Type Predict the Subsequent Assault?
PMID 42307952 — clinical medicine
JAMA Netw Open20260
Patient-reported outcome measures-guided perioperative care versus standard of care in postoperative recovery: Randomised controlled trial in orthopaedic surgery.
PMID 42290213 — anesthesiology, probability, health status, recycling, perioperative care, patient reported outcome measures
Eur J Anaesthesiol20260
Neurological outcomes after out-of-hospital cardiac arrest due to aneurysmal subarachnoid hemorrhage: a multicenter cohort study.
PMID 42271417 — hemorrhage, brain, aneurysm, cohort studies, out-of-hospital cardiac arrest, subarachnoid hemorrhage, epinephrine, brain death, heart arrest, therapeutics, prognosis
Crit Care20260
High-speed trains versus air transport vectors for mass transfers of critically ill patients: The TRANSCOV cohort study.
PMID 42048328 — cohort studies, air, critical illness, intensive care units
PLoS One20260

Clinical Studies 63

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 10 Study Director: 3

By phase:

N/A 35
Phase 3 19
Phase 2 4
Phase 2/Phase 3 4
Phase 4 1

By status:

Completed 34
Unknown 13
Recruiting 11
Not yet recruiting 2
Terminated 2
Active not recruiting 1

By type:

Interventional 44
Observational 19

By Monocentric/Multicentric:

monocentric 26
multicentric2to4 7
multicentric5to9 4
multicentricup10 26

Main Topics

Cohort/Consortium Investigators 9

Ongoing Clinical Trials

10 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study Evaluating Multifaceted Support for the Implementation of Recommendations for the Prevention and Management of Anemia in Intensive Care Units
NCT07771192 — anemia, hospital mortality, intensive care units
N/ANot yet recruiting2026
ASPIC Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care
2024-513327-16-00 — pneumonia, ventilator-associated, antimicrobial stewardship, pneumonia
Phase 3Recruiting2022
Efficacy of early Argipressin (arginine vasopressin) in the management of intensive care patients with norepinephrine refractory vasoplegic shock a multicentric randomized double blind placebo controlled superiority trial Vaso R
2024-516639-28-00 — arginine vasopressin, arginine, norepinephrine, therapeutics
Phase 3Recruiting2026
Efficacy of daily IV administration of dornase alfa for up to 14 days post subarachnoid haemorrhage on functional independence at 6 months a multicentre open label randomised controlled trial of the PROBE type Probe
2023-509627-40-01 — hemorrhage, subarachnoid hemorrhage
Phase 3Recruiting2025
Intermediate Versus Standard Dose Enoxaparin to Prevent Venous Thromboembolism in Severe Trauma Patients a Multicenter Double Blind Randomised Controlled Trial
NCT07506473 — injections, anticoagulants, enoxaparin, thromboembolism, incidence, heparin, venous thromboembolism, thrombosis, heparin, low-molecular-weight, wounds and injuries, injections, subcutaneous, veins
N/ANot yet recruiting2026

LeadR Networks

Main global connection map